Denali Therapeutics shares owned by Skandinaviska Enskilda Banken AB
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Skandinaviska Enskilda Banken AB
from 13F filings
Historical chart of Skandinaviska Enskilda Banken AB investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Denali Therapeutics by Skandinaviska Enskilda Banken AB
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $7.2M | 348k | 20.63 |
2023-06-30 | $10M | 348k | 29.51 |
2023-03-31 | $7.1M | 307k | 23.04 |
2022-12-31 | $8.6M | 309k | 27.81 |
2022-09-30 | $8.9M | 291k | 30.69 |
2022-06-30 | $6.3M | 213k | 29.43 |
2022-03-31 | $4.5M | 139k | 32.17 |
2021-12-31 | $6.2M | 139k | 45.05 |
2021-09-30 | $6.7M | 132k | 50.45 |
2021-06-30 | $2.3M | 30k | 78.43 |
2021-03-31 | $1.5M | 26k | 57.09 |
2020-12-31 | $2.2M | 26k | 83.75 |
More positions owned by Skandinaviska Enskilda Banken AB
View all positions for Skandinaviska Enskilda Banken AB